Wird geladen...

From differences in means between cases and controls to risk stratification: A business plan for biomarker development

Researchers developing biomarkers for early detection can determine the potential for clinical benefit at early stages of development. We provide the theoretical background showing the quantitative connection between biomarker levels in cases and controls and clinically meaningful risk measures and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wentzensen, Nicolas, Wacholder, Sholom
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570740/
https://ncbi.nlm.nih.gov/pubmed/23299199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-12-0196
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!